Stemming from Rheumatic Fever, Rheumatic Heart Disease is a chronic heart condition. Rheumatic Fever is a disease that develops from an infection with A Streptococcus bacteria and can affect many parts of the body including the heart, joints, and brain. Infections with these bacteria begin as strep throat or scarlet fever and evolve into Rheumatic Fever if they are not treated. Most common in children between the ages of 5 to 15, Rheumatic Heart Disease is caused by the improper treatment or recurrence of Rheumatic Fever. Rheumatic Heart Disease is usually treated with surgery to repair or replace heart valves. Because of the common occurrence in developing countries, access to medical procedures is limited; subsequently, many children die of Rheumatic Heart Disease each year.
Rheumatic Heart Disease Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Rheumatic Heart Disease below!
For more information on how to use Laverne, please read the How to Guide.
We have 1749 products for the study of Rheumatic Heart Disease that can be applied to Flow Cytometry, Western Blot, Immunocytochemistry/Immunofluorescence, Chromatin Immunoprecipitation (ChIP), Immunohistochemistry from our catalog of antibodies and ELISA kits.
Rheumatic Heart Disease is also known as Disease, Rheumatic Heart, Diseases, Rheumatic Heart, Heart Disease, Rheumatic, Heart Diseases, Rheumatic, Rhd.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.